Medicare Rx Debate Moves To Center Of Presidential Campaigns
The outcome of House/Senate negotiations over drug re-importation and taxpayer funded research will be the most pressing pharmaceutical-related issues in Washington, D.C., as the Medicare drug benefit debate takes center stage in the Presidential campaign.
You may also be interested in...
Licensed pharmacists should have the same right to import and re-import prescription drugs as manufacturers, the National Community Pharmacists Association maintained in an Aug. 24 letter to the House and Senate conferees on the Agriculture Appropriations bill (HR 4461).
Vice President Al Gore highlighted his willingness to fight pharmaceutical industry pressure as a point of difference between himself and Texas Gov. George W. Bush during his acceptance speech at the Democratic national convention Aug. 17 in Los Angeles.
Medicare would contract with multiple pharmaceutical benefit managers in each service area under Sen. Roth's (R-Del.) Medicare reform plan.